Physician profile
Charles Bratton
NPI 1982710869
$1,983.43
in general payments reported to CMS, 2019-2025
16 companies · $121 in 2025
The $121 reported for 2025 was less than what a typical Transplant Surgery provider received nationally (typical 2025 total: $423).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $384 · 2020: $49.84 · 2021: $79.64 · 2022: $272 · 2023: $457 · 2024: $621 · 2025: $121.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,198.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,198.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ethicon US, LLC | $427.37 | 2022-2023 | Vistaseal, Evarrest, Dermabond Prineo |
| Veloxis Pharmaceuticals, INC. | $399.50 | 2019-2024 | Envarsus |
| Mallinckrodt Hospital Products INC. | $254.73 | 2022-2024 | Terlivaz |
| Abbvie INC. | $223.05 | 2022-2025 | |
| Paragonix Technologies, INC. | $153.90 | 2024 | Lungguard, Baroguard, Sherpapak |
| Integra Lifesciences Corporation | $98.41 | 2021-2025 | Duraseal Exact Spinal Sealant System, Codman Certas, Codman Hakim |
| Haemonetics Corporation | $81.40 | 2019 | |
| Baxter Healthcare | $57.70 | 2020-2021 | |
| One Lambda, INC. | $49.86 | 2024 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $48.96 | 2023-2024 | Xifaxan |
| Histosonics, INC. | $46.46 | 2024 | |
| Olympus America INC. | $37.17 | 2025 | Olympus |
| Hemosonics LLC | $35.58 | 2023 | Quantra Qplus System |
| Takeda Pharmaceuticals U.S.A., INC. | $33.14 | 2025 | Livtencity |
| Xvivo Perfusion INC. | $19.82 | 2024 | Xvivo Perfusion System (Xps) |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Eurofins Viracor, LLC | $16.38 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Charles Bratton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.